E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/1/2010 in the Prospect News PIPE Daily.

MedMira heralds private placement of C$1 million convertible debenture

Offering of 5% debentures due Sept. 30, 2013 conducted with Andurja

By Devika Patel

Knoxville, Tenn., Oct. 1 - MedMira Inc. said it plans a private placement of convertible debentures with Andurja AG. The offering will raise C$1 million.

The 5% debentures are convertible into shares at C$0.05 per share and mature on Sept. 30, 2013.

The strike price represents a 42.86% premium to the Sept. 30 closing share price of C$0.035.

MedMira, based in Halifax, N.S., manufactures and markets in vitro flow-through rapid diagnostic tests.

Issuer:MedMira Inc.
Issue:Convertible debentures
Amount:C$1 million
Maturity:Sept. 30, 2013
Coupon:5%
Conversion price:C$0.05
Warrants:No
Investor:Andurja AG
Pricing date:Oct. 1
Stock symbol:TSX Venture: MIR
Stock price:C$0.035 at close Oct. 1
Market capitalization:C$7.05 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.